Medmix Ltd
SIX:MEDX

Watchlist Manager
Medmix Ltd Logo
Medmix Ltd
SIX:MEDX
Watchlist
Price: 8.65 CHF 0.12% Market Closed
Market Cap: 352.8m CHF
Have any thoughts about
Medmix Ltd?
Write Note

Intrinsic Value

The intrinsic value of one MEDX stock under the Base Case scenario is 24.06 CHF. Compared to the current market price of 8.65 CHF, Medmix Ltd is Undervalued by 64%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MEDX Intrinsic Value
24.06 CHF
Undervaluation 64%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Medmix Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MEDX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MEDX?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Medmix Ltd

Provide an overview of the primary business activities
of Medmix Ltd.

What unique competitive advantages
does Medmix Ltd hold over its rivals?

What risks and challenges
does Medmix Ltd face in the near future?

Has there been any significant insider trading activity
in Medmix Ltd recently?

Summarize the latest earnings call
of Medmix Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medmix Ltd.

Provide P/S
for Medmix Ltd.

Provide P/E
for Medmix Ltd.

Provide P/OCF
for Medmix Ltd.

Provide P/FCFE
for Medmix Ltd.

Provide P/B
for Medmix Ltd.

Provide EV/S
for Medmix Ltd.

Provide EV/GP
for Medmix Ltd.

Provide EV/EBITDA
for Medmix Ltd.

Provide EV/EBIT
for Medmix Ltd.

Provide EV/OCF
for Medmix Ltd.

Provide EV/FCFF
for Medmix Ltd.

Provide EV/IC
for Medmix Ltd.

Show me price targets
for Medmix Ltd made by professional analysts.

What are the Revenue projections
for Medmix Ltd?

How accurate were the past Revenue estimates
for Medmix Ltd?

What are the Net Income projections
for Medmix Ltd?

How accurate were the past Net Income estimates
for Medmix Ltd?

What are the EPS projections
for Medmix Ltd?

How accurate were the past EPS estimates
for Medmix Ltd?

What are the EBIT projections
for Medmix Ltd?

How accurate were the past EBIT estimates
for Medmix Ltd?

Compare the revenue forecasts
for Medmix Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medmix Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medmix Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medmix Ltd compared to its peers.

Compare the P/E ratios
of Medmix Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Medmix Ltd with its peers.

Analyze the financial leverage
of Medmix Ltd compared to its main competitors.

Show all profitability ratios
for Medmix Ltd.

Provide ROE
for Medmix Ltd.

Provide ROA
for Medmix Ltd.

Provide ROIC
for Medmix Ltd.

Provide ROCE
for Medmix Ltd.

Provide Gross Margin
for Medmix Ltd.

Provide Operating Margin
for Medmix Ltd.

Provide Net Margin
for Medmix Ltd.

Provide FCF Margin
for Medmix Ltd.

Show all solvency ratios
for Medmix Ltd.

Provide D/E Ratio
for Medmix Ltd.

Provide D/A Ratio
for Medmix Ltd.

Provide Interest Coverage Ratio
for Medmix Ltd.

Provide Altman Z-Score Ratio
for Medmix Ltd.

Provide Quick Ratio
for Medmix Ltd.

Provide Current Ratio
for Medmix Ltd.

Provide Cash Ratio
for Medmix Ltd.

What is the historical Revenue growth
over the last 5 years for Medmix Ltd?

What is the historical Net Income growth
over the last 5 years for Medmix Ltd?

What is the current Free Cash Flow
of Medmix Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medmix Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Medmix Ltd

Balance Sheet Decomposition
Medmix Ltd

Current Assets 326.4m
Cash & Short-Term Investments 140.7m
Receivables 87.4m
Other Current Assets 98.3m
Non-Current Assets 710m
Long-Term Investments 13.6m
PP&E 263.8m
Intangibles 398.5m
Other Non-Current Assets 34.1m
Current Liabilities 220.8m
Accounts Payable 49m
Other Current Liabilities 171.8m
Non-Current Liabilities 354.7m
Long-Term Debt 306.3m
Other Non-Current Liabilities 48.4m
Efficiency

Earnings Waterfall
Medmix Ltd

Revenue
479.7m CHF
Cost of Revenue
-323.4m CHF
Gross Profit
156.3m CHF
Operating Expenses
-140.2m CHF
Operating Income
16.1m CHF
Other Expenses
-17.9m CHF
Net Income
-1.8m CHF

Free Cash Flow Analysis
Medmix Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MEDX Profitability Score
Profitability Due Diligence

Medmix Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
47/100
Profitability
Score

Medmix Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

MEDX Solvency Score
Solvency Due Diligence

Medmix Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
41/100
Solvency
Score

Medmix Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MEDX Price Targets Summary
Medmix Ltd

Wall Street analysts forecast MEDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDX is 25.5 CHF with a low forecast of 25.25 CHF and a high forecast of 26.25 CHF.

Lowest
Price Target
25.25 CHF
192% Upside
Average
Price Target
25.5 CHF
195% Upside
Highest
Price Target
26.25 CHF
203% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MEDX?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MEDX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MEDX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Medmix Ltd Logo
Medmix Ltd

Country

Switzerland

Industry

Health Care

Market Cap

352.8m CHF

Dividend Yield

5.78%

Description

medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The company is headquartered in Zug, Zug and currently employs 2,101 full-time employees. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.

Contact

ZUG
Zug
Dammstrasse 19
+41417237300
www.medmix.ch

IPO

-

Employees

2 101

Officers

Chief Executive Officer
Mr. Girts Cimermans
Chief Financial Officer
Ms. Jennifer Dean
Head of M&A, Strategy & Investor Relations
Ms. Sheel Gill
Chief Legal Officer, Company Secretary & Head of Corporate Affairs
Mr. Schops Xavier
Chief Human Resources, Sustainability & Communications Officer
Ms. Itee Satpathy

See Also

Discover More
What is the Intrinsic Value of one MEDX stock?

The intrinsic value of one MEDX stock under the Base Case scenario is 24.06 CHF.

Is MEDX stock undervalued or overvalued?

Compared to the current market price of 8.65 CHF, Medmix Ltd is Undervalued by 64%.

Back to Top